We are live on ! Find out more
GTHX

G1 Therapeutics, Inc. Common Stock
GTHX

Delisted

GTHX was delisted on the 17th of September, 2024.

Back to rankings

94 hedge funds and large institutions have $741M invested in G1 Therapeutics, Inc. Common Stock in 2018 Q1 according to their latest regulatory filings, with 42 funds opening new positions, 37 increasing their positions, 11 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

950% more first-time investments, than exits

New positions opened: 42 | Existing positions closed: 4

236% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 11

175% more capital invested

Capital invested by funds: $270M → $741M (+$471M)

65% more funds holding

Funds holding: 57 → 94 (+37)

Holders
94
Holders Change
+37
Holders Change %
+64.91%
% of All Funds
2.15%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
42
Increased
37
Reduced
11
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
+$32.6M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$29.8M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$19.7M
4
BlackRock
BlackRock
New York
+$14.3M
5
Capital World Investors
Capital World Investors
California
+$12.7M

Top Sellers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
-$6.08M
2
CAM
Cormorant Asset Management
Massachusetts
-$4.74M
3
RCM
RA Capital Management
Massachusetts
-$3.2M
4
EA
Emerald Advisers
Pennsylvania
-$508K
5
EMG
Ellington Management Group
Connecticut
-$294K
Name Holding Trade Value Shares
Change 		Change in
Stake
CIP
26
Chartwell Investment Partners
Pennsylvania
$3.13M -$48.9K -1,833 -2%
Bank of New York Mellon
27
Bank of New York Mellon
New York
$2.93M +$1.33M +49,710 +169%
USAA
28
United Services Automobile Association
Texas
$2.55M +$1.84M +68,812 New
MIM
29
Monashee Investment Management
Massachusetts
$2.52M +$1.81M +68,000 New
Russell Investments Group
30
Russell Investments Group
United Kingdom
$1.84M +$190K +7,126 +17%
Victory Capital Management
31
Victory Capital Management
Texas
$1.74M -$126K -4,720 -9%
Two Sigma Investments
32
Two Sigma Investments
New York
$1.57M +$465K +17,432 +70%
RCM
33
RA Capital Management
Massachusetts
$1.48M -$3.2M -119,780 -75%
Norges Bank
34
Norges Bank
Norway
$1.48M – – –
PPA
35
Parametric Portfolio Associates
Washington
$1.42M +$1.02M +38,374 New
AA
36
ALPS Advisors
Colorado
$1.41M +$180K +6,742 +21%
VEA
37
Virtus ETF Advisers
New York
$1.41M +$546K +20,478 +116%
Swiss National Bank
38
Swiss National Bank
Switzerland
$1.31M +$563K +21,100 +147%
Deutsche Bank
39
Deutsche Bank
Germany
$1.31M +$431K +16,140 +84%
LCM
40
Laurion Capital Management
New York
$1.26M +$908K +34,016 New
Renaissance Technologies
41
Renaissance Technologies
New York
$1.19M +$854K +32,000 New
Ameriprise
42
Ameriprise
Minnesota
$1.14M +$821K +30,769 New
Morgan Stanley
43
Morgan Stanley
New York
$1.14M +$388K +14,551 +90%
Charles Schwab
44
Charles Schwab
California
$1.07M +$382K +14,300 +98%
EGI
45
EAM Global Investors
California
$1.06M +$766K +28,713 New
TCIM
46
TIAA CREF Investment Management
New York
$1.01M +$264K +9,899 +57%
TD Asset Management
47
TD Asset Management
Ontario, Canada
$957K +$689K +25,836 New
TA
48
Teachers Advisors
New York
$911K +$287K +10,762 +78%
BC
49
Birchview Capital
Vermont
$815K +$587K +22,000 New
California State Teachers Retirement System (CalSTRS)
50
California State Teachers Retirement System (CalSTRS)
California
$762K +$216K +8,076 +65%
1
2
3 4

GTHX Hedge Fund Activity: Q1 2018 in Review

94 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in G1 Therapeutics, Inc. Common Stock (GTHX) for Q1 2018, worth a combined $741M — up 175% from $270M a quarter earlier.

Buyers outnumbered sellers: 42 funds opened new GTHX positions and 4 closed out — a net gain of 38 holders — while 37 added to existing stakes and 11 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $32.6M. The largest seller was Franklin Resources, cutting an estimated $6.08M.

  • 94 institutional investors held G1 Therapeutics, Inc. Common Stock (GTHX) as of Q1 2018, up from 57 in Q4 2017.
  • Funds reported $741M of G1 Therapeutics, Inc. Common Stock stock for Q1 2018, up 175% quarter-over-quarter.
  • 42 funds opened new G1 Therapeutics, Inc. Common Stock positions in Q1 2018 and 4 closed out, a net change of +38 holders.
  • The largest G1 Therapeutics, Inc. Common Stock buyer in Q1 2018 was Wellington Management Group, an estimated $32.6M added.
  • The largest G1 Therapeutics, Inc. Common Stock seller in Q1 2018 was Franklin Resources, an estimated $6.08M sold.

Based on aggregated 13F filings for Q1 2018.